Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 180

1.

Lack of plasma interleukin-1 beta or tumor necrosis factor-alpha elevation during unfavorable hemodialysis conditions.

Powell AC, Bland LE, Oettinger CW, McAllister SK, Oliver JC, Arduino MJ, Favero MS.

J Am Soc Nephrol. 1991 Nov;2(5):1007-13.

2.

The effects of peritoneal dialysis and hemodialysis on serum tumor necrosis factor-alpha, interleukin-6, interleukin-10 and C-reactive-protein levels.

Borazan A, Ustün H, Ustundag Y, Aydemir S, Bayraktaroglu T, Sert M, Yilmaz A.

Mediators Inflamm. 2004 Jun;13(3):201-4.

3.

Balance between IL-1 beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes.

Descamps-Latscha B, Herbelin A, Nguyen AT, Roux-Lombard P, Zingraff J, Moynot A, Verger C, Dahmane D, de Groote D, Jungers P, et al.

J Immunol. 1995 Jan 15;154(2):882-92.

PMID:
7814891
4.

Plasma lipopolysaccharide binding protein and bactericidal/permeability increasing factor in CRF and HD patients.

Pereira BJ, Sundaram S, Snodgrass B, Hogan P, King AJ.

J Am Soc Nephrol. 1996 Mar;7(3):479-87.

5.

Interleukin-8 in chronic renal failure and dialysis patients.

Nakanishi I, Moutabarrik A, Okada N, Kitamura E, Hayashi A, Syouji T, Namiki M, Ishibashi M, Zaid D, Tsubakihara Y.

Nephrol Dial Transplant. 1994;9(10):1435-42.

PMID:
7816257
6.

The study of IL-1 beta, TNF-alpha, IL-6 gene expression and plasma levels on hemodialysis before and after dialyzer reuse.

Qian J, Yu Z, Dai H, Huang P, Zhang Q, Cheng F, Chen S.

Chin Med J (Engl). 1997 Jul;110(7):508-11.

PMID:
9594206
7.

Acute effect of hemodialysis on serum levels of the proinflammatory cytokines.

Tarakçioğlu M, Erbağci AB, Usalan C, Deveci R, Kocabaş R.

Mediators Inflamm. 2003 Feb;12(1):15-9.

8.

Pro- and anti-inflammatory cytokines in chronic pediatric dialysis patients: effect of aspirin.

Goldstein SL, Leung JC, Silverstein DM.

Clin J Am Soc Nephrol. 2006 Sep;1(5):979-86. Epub 2006 Aug 16.

9.

Cytokine profiles during clinical high-flux dialysis: no evidence for cytokine generation by circulating monocytes.

Grooteman MP, Nubé MJ, Daha MR, Van Limbeek J, van Deuren M, Schoorl M, Bet PM, Van Houte AJ.

J Am Soc Nephrol. 1997 Nov;8(11):1745-54.

10.

Blood serum levels of IL-2, IL-6, IL-8, TNF-alpha and IL-1beta in patients on maintenance hemodialysis.

Rysz J, Banach M, Cialkowska-Rysz A, Stolarek R, Barylski M, Drozdz J, Okonski P.

Cell Mol Immunol. 2006 Apr;3(2):151-4.

11.

Can the inflammation markers of patients with high peritoneal permeability on continuous ambulatory peritoneal dialysis be reduced on nocturnal intermittent peritoneal dialysis?

Cueto-Manzano AM, Rojas-Campos E, Martínez-Ramírez HR, Valera-González I, Medina M, Monteón F, Ruiz N, Becerra M, Palomeque MA, Cortés-Sanabria L.

Perit Dial Int. 2006 May-Jun;26(3):341-8.

PMID:
16722027
12.

Increased endothelin-1 mRNA expression in peripheral blood monocytes of dialysis patients.

Ebihara I, Nakamura T, Takahashi T, Tomino Y, Shimada N, Koide H.

Perit Dial Int. 1997 Nov-Dec;17(6):595-601.

PMID:
9655160
14.

TNF-alpha: mRNA, plasma protein levels and soluble receptors in patients on chronic hemodialysis, on CAPD and with end-stage renal failure.

van Riemsdijk-van Overbeeke IC, Baan CC, Hesse CJ, Loonen EH, Niesters HG, Zietse R, Weimar W.

Clin Nephrol. 2000 Feb;53(2):115-23.

PMID:
10711413
15.

Enhanced release of TNF-alpha, but not IL-1 beta, from uremic blood after endotoxin stimulation.

Powell AC, Bland LA, Oettinger CW, McAllister SK, Oliver JC, Arduino MJ, Favero MS.

Lymphokine Cytokine Res. 1991 Oct;10(5):343-6.

PMID:
1768736
16.

Impairment of innate cellular response to in vitro stimuli in patients on continuous ambulatory peritoneal dialysis.

Ando M, Shibuya A, Yasuda M, Azuma N, Tsuchiya K, Akiba T, Nitta K.

Nephrol Dial Transplant. 2005 Nov;20(11):2497-503. Epub 2005 Aug 2.

PMID:
16077138
17.

Tumor necrosis factor-alpha during continuous high-flux hemodialysis in sepsis with acute renal failure.

Lonnemann G, Bechstein M, Linnenweber S, Burg M, Koch KM.

Kidney Int Suppl. 1999 Nov;(72):S84-7.

PMID:
10560813
18.

The effects of hemodialysis (HD) membranes on interleukin 1-beta (IL-1 beta) production from peripheral blood mononuclear cells (PBMC).

Momoi T, Ono M, Takagi T, Sugiura S, Ogawa H, Saito A.

Clin Nephrol. 1995 Nov;44 Suppl 1:S24-8.

PMID:
8608657
19.
20.

Comparison of hemostatic disturbances between patients on CAPD and patients on hemodialysis.

Malyszko J, Malyszko JS, Mysliwiec M.

Perit Dial Int. 2001 Mar-Apr;21(2):158-65.

PMID:
11330560

Supplemental Content

Support Center